Evidence map›Paper›PMID 34081210›Full record

ReviewCurrent cardiology reports2021

Potential Cardiac Amyloid PET/CT Imaging Targets for Differentiating Immunoglobulin Light Chain From Transthyretin Amyloidosis.

Thomas Hellmut Schindler, Monica Sharma, Ines Valenta, Alessio Imperiale, Vasken Dilsizian

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current cardiology reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Hot spot imaging in cardiovascular diseases: an information statement from SNMMI, ASNC, and EANM.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Thomas Hellmut SchindlerMallinckrodt Institute of Radiology, Division of Nuclear Medicine, Washington University in St. Louis School of Medicine, 510 S. Kingshighway Boulevard, Campus Box 8223, St. Louis, MO, 63110, USA. thschindler@wustl.edu.ORCID http://orcid.org/0000-0002-2141-7716
Monica SharmaDepartment of Biomedical Engineering, School of Engineering & Applied Science, Washington University, St. Louis, MO, 63110, USA.
Ines ValentaMallinckrodt Institute of Radiology, Division of Nuclear Medicine, Washington University in St. Louis School of Medicine, 510 S. Kingshighway Boulevard, Campus Box 8223, St. Louis, MO, 63110, USA.
Alessio ImperialeBiophysics and Nuclear Medicine, University Hospitals of Strasbourg, 67000, Strasbourg, France.
Vasken DilsizianUniversity of Maryland School of Medicine, Division of Nuclear Medicine, Baltimore, MD, 21201, USA.
Washington University in St. Louis · USUniversité de Strasbourg · FRUniversity of Maryland, Baltimore · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of the reviewCardiac involvement in amyloidosis plays a critical role in the clinical manifestation and prognostication. Since advanced treatment options for immunoglobulin light chains (AL) or liver-generated protein transthyretin (TTR) are quite different, a non-invasive and comprehensive imaging approach for the identification and characterization of these forms of cardiac amyloidosis is warranted. RECENT

findingsVarious

Indexed as

Amyloid Neuropathies, FamilialCardiomyopathiesHumansImmunoglobulin Light ChainsPositron-Emission TomographyPositron Emission Tomography Computed TomographyImmunoglobulin Light Chains18F-labeled radiotracersAmyloidosisCardiac involvementImmunoglobulin light chainsPositron emission tomographyTransthyretin

Identifiers

PMID34081210
OpenAlexW3165364283

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.